#395 - Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer's disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.
Dr. Tom Dayspring returns to discuss the distinct cholesterol system of the brain, its independence from peripheral metabolism, and the roles of apoB, apoA-I, and apoE in brain health. He explores how APOE genotype influences Alzheimer's risk and the impact of lipid-lowering therapies on neurodegenerative diseases.
Deep Dive Analysis
22 Topic Outline
Fundamentals of Peripheral Cholesterol Transport
Cellular Cholesterol Synthesis and Export
ApoA1 and HDL Formation
ApoB Lipoproteins: VLDL, LDL, Chylomicrons
LDL's Role in Reverse Cholesterol Transport
Plasma vs. Total Body Cholesterol Distribution
Pathophysiology of Atherosclerosis and ApoB
Factors Influencing Individual Atherosclerosis Risk
Brain's Independent Cholesterol System
Cholesterol Synthesis in Fetal and Adult Brain
ApoE's Role in Brain Lipid Transport
LDL Receptor and LRP1 in Brain Cholesterol Uptake
Desmosterol and Lithosterol Pathways in Brain
APOE Gene vs. ApoE Protein and Alzheimer's Risk
HDL Function Beyond Cholesterol Transport
APOE4 Defects and Alzheimer's Disease Mechanism
Brain Cholesterol, Amyloid, and Tau Relationship
24S-hydroxycholesterol as Brain Health Biomarker
Statins and Brain Health: Hydrophilic vs. Lipophilic
Potential Cognitive Benefits of Ezetimibe
Role of EPA and DHA in Brain Health
Obicetrapib and CETP Inhibitors for Brain Health
10 Key Concepts
Lipoproteins
Proteins that bind to hydrophobic lipids like cholesterol and triglycerides, forming particles that allow these lipids to circulate in the aqueous environment of plasma.
ApoB Family Lipoproteins
A class of larger lipoproteins (VLDL, LDL, chylomicrons) characterized by the ApoB protein, which are primarily responsible for transporting cholesterol and triglycerides and are the main drivers of atherosclerosis.
Reverse Cholesterol Transport
The process by which excess cholesterol is removed from peripheral cells and returned to the liver, either directly by HDLs or indirectly, with LDLs playing a significant role in returning cholesterol to the liver.
Blood-Brain Barrier (BBB)
A highly selective barrier that separates the circulating blood from the brain's extracellular fluid, preventing most large molecules, including ApoB-containing lipoproteins, from entering the brain.
Brain Cholesterol Homeostasis
The brain's independent system for synthesizing, transporting, and clearing its own cholesterol, which operates almost entirely separately from the peripheral cholesterol system due to the blood-brain barrier.
ApoE (Apolipoprotein E)
The primary apolipoprotein in the brain, synthesized by astrocytes, which forms lipoproteins to transport cholesterol within the brain's interstitial tissue (matrosome) to neurons for their essential functions.
APOE Genotype
Genetic variations (e.g., E2, E3, E4) that determine the specific isoform of the apoE protein an individual produces. The APOE4 genotype is strongly associated with an increased risk of Alzheimer's disease due to dysfunctional apoE protein.
Desmosterol Pathway
One of the two main cholesterol synthesis pathways, which is predominantly utilized in the brain (especially by astrocytes) and steroidogenic tissues. Plasma desmosterol levels can serve as a biomarker for brain cholesterol production.
24S-hydroxycholesterol
An oxysterol produced by neurons from excess cholesterol. It is more water-soluble than cholesterol, allowing it to cross the blood-brain barrier and be excreted via the liver, serving as a biomarker for brain cholesterol efflux and health.
Amyloid Precursor Protein
A protein embedded in neuron cell membranes that, when cholesterol balance is disrupted, can be cleaved by specific enzymes (secretases) to produce toxic beta-amyloid 42, contributing to Alzheimer's pathology.
10 Questions Answered
Cholesterol is critical because its most important function is positioning itself in cell membranes, regulating cell integrity and function, and it is also used for making vital hormones.
Lipids, being hydrophobic, cannot circulate freely in plasma; instead, proteins called apolipoproteins bind to them, wrapping them into lipoprotein particles that are soluble in water for transport.
The primary function of LDLs is to return cholesterol to the liver, rather than delivering it to cells, as most cells can synthesize all the cholesterol they need internally.
No, lowering peripheral LDL cholesterol does not deplete or injure the brain because the brain's cholesterol system operates almost entirely independently of circulating plasma cholesterol and ApoB-containing lipoproteins.
The brain has the highest concentration of cholesterol in the body, storing 20 times more than the liver, because it requires vast amounts for cell membrane integrity, especially in neurons, and for creating myelin sheaths around nerve endings.
Within the brain, cholesterol is transported between cells in the interstitial tissue (matrosome) via ApoE-containing lipoproteins, which are synthesized by astrocytes and delivered to neurons through LDL receptors and LRP1.
The APOE gene (all caps) refers to the specific genotype inherited from parents, while the apoE protein (small 'a') refers to the actual protein produced, which comes in different isoforms (E2, E3, E4) based on the gene, affecting its function.
APOE4 produces a dysfunctional apoE protein that impairs cholesterol transport into neurons, leading to disrupted cholesterol balance in cell membranes, which promotes the production of toxic beta-amyloid 42 and tau pathology.
Statins can cross the blood-brain barrier and reduce cholesterol synthesis in the brain. Meta-analyses generally show neutrality or a reduction in Alzheimer's disease incidence or cognitive impairment, though over-suppression can cause transient brain fog.
Ingested omega-3s are absorbed as free fatty acids or lysophospholipids, then packaged into chylomicrons and subsequently bound to phospholipid transfer proteins, which can cross the blood-brain barrier via specific receptors.
8 Actionable Insights
1. Prioritize Low ApoB for Atherosclerosis
Actively work to lower your ApoB concentration, as ApoB-containing particles are the primary drivers of atherosclerosis by entering artery walls and forming plaque. Lowering ApoB is critical for preventing cardiovascular disease.
2. Address Metabolic Health for Atherosclerosis
Improve your metabolic health, as conditions like insulin resistance, chronic inflammation, and endothelial damage make it easier for ApoB particles to invade artery walls, accelerating atherosclerosis development.
3. Avoid High LDL Cholesterol Risk
Do not assume you are genetically protected against high LDL cholesterol. For the vast majority, high levels lead to pathology, so take action to lower it rather than playing ‘Russian roulette’ with your health.
4. Understand Statin Brain Effects
Be aware that statins can cross the blood-brain barrier and reduce brain cholesterol synthesis. While generally neutral or beneficial for cognition, be mindful of acute brain fog, which may indicate over-suppression and could warrant dose adjustment or alternative lipid-lowering therapies.
5. Consider Plasma Desmosterol Monitoring
If on statin therapy, consider monitoring plasma desmosterol levels. Low desmosterol correlates with higher cognitive impairment and Alzheimer’s, suggesting potential over-suppression of brain cholesterol synthesis, which might require adjusting statin dosage.
6. Explore Ezetimibe for Brain Health
Discuss ezetimibe with your doctor, as its metabolite can cross the blood-brain barrier and has shown anecdotal cognitive benefits and interference with brain protein glycosylation, potentially reducing inflammation in the brain.
7. Aim for Optimal Omega-3 Index
Strive to achieve an omega-3 index of 8-9% in your red blood cell membranes. Observational data suggests this range is associated with better brain health and reduced cardiovascular risk, with little downside to supplementation.
8. Investigate CETP Inhibitors for Brain
Stay informed about emerging CETP inhibitors like Obicetrapib. These drugs show promise in improving Alzheimer’s biomarkers and may increase protective ApoA1 and functional HDL species in the brain, potentially rescuing dysfunctional ApoE4 particles.
8 Key Quotes
If you have atherosclerosis, there's one sine qua non, you have cholesterol buildup in your artery wall.
Tom Dayspring
The brain of all the organs in the body has 20 times more cholesterol than does the liver.
Tom Dayspring
What's going on with cholesterol in the brain, how much cholesterol is stored in the brain has zero to do with what is floating in the plasma.
Tom Dayspring
The neuron does not want to waste ATPs making cholesterol if it can get it elsewhere.
Tom Dayspring
The type of ApoE you manufacture is critical to certain disease pathologies.
Tom Dayspring
The most important thing about the peripheral HDLs is not the amount of cholesterol they traffic. It's kind of trivial and it gets transferred here and there. And it almost tells us nothing.
Tom Dayspring
Don't ever think because your LDL cholesterol is 200 that I'm one of them because there's no way to know that. Why play Russian roulette and think it's not going to bother me when for the vast majority of people, it does create havoc and pathology.
Tom Dayspring
If your total cholesterol falls from 200 to 100 milligrams per deciliter, it's tempting to think, oh my gosh, my total body cholesterol has fallen by half. In reality, it's fallen by a couple of percent because it's a tiny, tiny amount.
Peter Attia